XML 36 R26.htm IDEA: XBRL DOCUMENT v3.19.1

Revenue (Tables)

3 Months Ended

Mar. 31, 2019

Revenue from Contract with Customer [Abstract]

Schedule of disaggregation of revenue

The following table summarizes revenue by product:

	Three Months Ended March 31,
	2019										2018
	United States (U.S.) (1)			Outside U.S.			Total				U.S. (1)			Outside U.S.			Total
Revenue—to unaffiliated customers:
Endocrinology:
Trulicity®	$	665.6		$	214.1		$	879.7			$	528.2		$	150.1		$	678.3
Humalog®	448.6			282.2			730.8				504.1			287.6			791.7
Forteo®	125.9			187.0			312.9				122.1			191.1			313.2
Humulin®	201.3			96.4			297.7				221.6			104.3			325.9
Basaglar®	198.2			53.2			251.4				126.7			39.3			166.0
Jardiance	125.2			78.4			203.6				95.0			56.0			151.0
Trajenta	47.4			84.6			131.9				54.1			87.0			141.1
Other Endocrinology	61.7			60.3			122.1				64.1			67.5			131.5
Total Endocrinology	1,873.9			1,056.2			2,930.1				1,715.9			982.9			2,698.7
Oncology:
Alimta®	281.8			217.4			499.2				245.3			254.3			499.6
Cyramza®	75.1			123.2			198.3				68.3			115.3			183.6
Erbitux®	113.3			5.1			118.4				121.3			28.3			149.6
Verzenio®	93.5			15.9			109.4				29.7			—			29.7
Other Oncology	30.2			57.3			87.4				45.6			48.4			94.1
Total Oncology	593.9			418.9			1,012.7				510.2			446.3			956.6
Neuroscience:
Cymbalta®	10.3			153.8			164.1				12.2			157.3			169.6
Zyprexa®	9.3			97.9			107.2				8.8			113.8			122.6
Strattera®	1.5			64.7			66.2				46.9			83.7			130.7
Emgality®	12.2			2.1			14.2				—			—			—
Other Neuroscience	17.8			23.5			41.4				23.3			26.7			49.8
Total Neuroscience	51.1			342.0			393.1				91.2			381.5			472.7
Immunology:
Taltz®	180.8			71.7			252.5				111.2			35.3			146.5
Other Immunology	6.4			75.7			82.2				—			32.2			32.2
Total Immunology	187.2			147.4			334.7				111.2			67.5			178.7
Other
Cialis®	143.2			164.9			308.2				313.4			182.0			495.4
Other	41.5			72.0			113.4				53.7			108.0			161.7
Total Other	184.7			236.9			421.6				367.1			290.0			657.1
Revenue	$	2,890.8		$	2,201.4		$	5,092.2			$	2,795.6		$	2,168.2		$	4,963.8

Numbers may not add due to rounding.

⁽¹⁾ U.S. revenue includes revenue in Puerto Rico.

The following table summarizes revenue by geographical area:

	Three Months Ended March 31,
	2019				2018
Revenue—to unaffiliated customers (1):
United States (2)	$	2,890.8			$	2,795.6
Europe	900.3				864.2
Japan	543.7				537.0
Other foreign countries	757.4				767.1
Revenue	$	5,092.2			$	4,963.8

Numbers may not add due to rounding.

⁽¹⁾ Revenue is attributed to the countries based on the location of the customer.

⁽²⁾ U.S. revenue includes revenue in Puerto Rico.

The following table summarizes our revenue recognized in our consolidated condensed statements of operations:

	Three Months Ended March 31,
	2019				2018
Net product revenue	$	4,692.3			$	4,605.9
Collaboration and other revenue (1)	399.9				357.9
Revenue	$	5,092.2			$	4,963.8

⁽¹⁾ Collaboration and other revenue associated with prior period transfers of intellectual property was $35.5 million and $50.1 million during the three months ended March 31, 2019 and 2018, respectively.

Schedule of amounts recorded for contract liabilities

The following table summarizes contract liability balances:

	March 31, 2019				December 31, 2018
Contract liabilities	$	286.4			$	298.7

X

- Definition

Tabular disclosure of contract balances and changes in contract balances.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130551-203045

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130545-203045

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration